 Merck Co Inc NYSE: MRK is in advanced talks to acquire Seagen Inc NASDAQ: SGEN, and an agreement on a purchase is expected in the next few weeks, Wall Street Journal reported citing people familiar with the matter. The potential deal could be worth roughly 40. 